
|Podcasts|June 14, 2023
Generational Perspectives in Multiple Sclerosis Care
Listen
0:00 / 0:00
Dr Krieger, Dr Brandstadter, and Dr Lublin discuss the advances made in recognizing and managing multiple sclerosis over the last few decades and the challenges that remain.
Advertisement
2:00 MS as a previously untreatable disease and evolution of DMTs
5:49 Progress in treating MS
8:18 Anti-CD20 B-cell therapies in MS
10:48 CNS agents to treat MS
12:00 Evolution of risk assessment in MS
16:38 Escalation vs high efficacy approach in MS
22:40 Disease activity/progression in MS
26:59 Progression independent of relapse in MS
28:30 Patient reported outcomes and shared decision making
34:04 MS care in older patients
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
POLARIS-AD Phase 3 Trial of PDE5 Inhibitor AR1001 Completes Treatment Phase With Favorable Safety Profile
2
Mitophagy Activator Urolithin A Enters Phase 2 Alzheimer Trial of APOE4 Carriers
3
Sanofi's Oral TREM2 Agonist SAR448851 Advances to Phase 2 TREMHANCE Trial in Early Alzheimer Disease
4
AD109 Accepted NDA, AXS-12 FDA Submission, Phase 2 CELIA Study Results
5


















